EGFR and oligodendroglial tumor: Even if the “classic profile” was not prevalent (∼15%) in AO, as compared to the proneural one (∼75%), this subclass allowed to distinguish oligodendroglial tumors with neither 1p/19q co-deletion nor IDH1 mutations but with EGFR gene amplification and chromosome 10 loss.